[go: up one dir, main page]

SE9500897D0 - The pharmacological use of certain cystine derivatives - Google Patents

The pharmacological use of certain cystine derivatives

Info

Publication number
SE9500897D0
SE9500897D0 SE9500897A SE9500897A SE9500897D0 SE 9500897 D0 SE9500897 D0 SE 9500897D0 SE 9500897 A SE9500897 A SE 9500897A SE 9500897 A SE9500897 A SE 9500897A SE 9500897 D0 SE9500897 D0 SE 9500897D0
Authority
SE
Sweden
Prior art keywords
pct
cysteine derivatives
pharmacological use
certain cysteine
derivatives
Prior art date
Application number
SE9500897A
Other languages
English (en)
Swedish (sv)
Inventor
Haakan Bergstrand
Knut Pettersson
Christer Westerlund
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9500897A priority Critical patent/SE9500897D0/xx
Publication of SE9500897D0 publication Critical patent/SE9500897D0/xx
Priority to TW085101975A priority patent/TW385249B/zh
Priority to ZA961749A priority patent/ZA961749B/xx
Priority to UA97105046A priority patent/UA42830C2/uk
Priority to JP8527519A priority patent/JPH11501916A/ja
Priority to KR1019970706464A priority patent/KR19980703055A/ko
Priority to SK1207-97A priority patent/SK282448B6/sk
Priority to CN96193717A priority patent/CN1183718A/zh
Priority to TR97/00945T priority patent/TR199700945T1/xx
Priority to BR9607225A priority patent/BR9607225A/pt
Priority to CZ19972804A priority patent/CZ288219B6/cs
Priority to PCT/SE1996/000320 priority patent/WO1996028149A1/fr
Priority to CA002214831A priority patent/CA2214831A1/fr
Priority to EP96906992A priority patent/EP0814798A1/fr
Priority to HU9801985A priority patent/HUP9801985A3/hu
Priority to EE9700229A priority patent/EE03382B1/xx
Priority to US08/619,681 priority patent/US5883126A/en
Priority to AU50185/96A priority patent/AU701287B2/en
Priority to ARP960101738A priority patent/AR002716A1/es
Priority to IL11746596A priority patent/IL117465A/xx
Priority to NZ303781A priority patent/NZ303781A/en
Priority to PL96322328A priority patent/PL183234B1/pl
Priority to IS4554A priority patent/IS4554A/is
Priority to MXPA/A/1997/006825A priority patent/MXPA97006825A/xx
Priority to NO974143A priority patent/NO974143D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9500897A 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives SE9500897D0 (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives
TW085101975A TW385249B (en) 1995-03-14 1996-02-16 Pharmaceutical compositions comprising certain cystine derivatives for use in prophylaxis and treatment of restenosis
ZA961749A ZA961749B (en) 1995-03-14 1996-03-04 The pharmacological use of certain cystine derivatives
AU50185/96A AU701287B2 (en) 1995-03-14 1996-03-12 The pharmacological use of certain cystine derivatives
CZ19972804A CZ288219B6 (en) 1995-03-14 1996-03-12 Medicament for prophylaxis or therapy of restenosis
HU9801985A HUP9801985A3 (en) 1995-03-14 1996-03-12 Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
KR1019970706464A KR19980703055A (ko) 1995-03-14 1996-03-12 특정 시스틴 유도체의 약물학적 용도
SK1207-97A SK282448B6 (sk) 1995-03-14 1996-03-12 Použitie derivátov cystínu
CN96193717A CN1183718A (zh) 1995-03-14 1996-03-12 胱氨酸衍生物的药理学应用
TR97/00945T TR199700945T1 (xx) 1995-03-14 1996-03-12 Baz� sistin t�revlerinin farmakolojik kullan�m�.
BR9607225A BR9607225A (pt) 1995-03-14 1996-03-12 Uso de composto preparação farmacêutica e processo para profilaxia ou para o tratamento de restenose em mamíferos inclusive seres humanos
UA97105046A UA42830C2 (uk) 1995-03-14 1996-03-12 Засіб для профілактики або лікування рестенозу, фармацевтичний препарат для лікування рестенозу, спосіб профілактики або лікування рестенозу
PCT/SE1996/000320 WO1996028149A1 (fr) 1995-03-14 1996-03-12 Utilisation pharmacologique de certains derives de la cystine
CA002214831A CA2214831A1 (fr) 1995-03-14 1996-03-12 Utilisation pharmacologique de certains derives de la cystine
EP96906992A EP0814798A1 (fr) 1995-03-14 1996-03-12 Utilisation pharmacologique de certains derives de la cystine
JP8527519A JPH11501916A (ja) 1995-03-14 1996-03-12 あるシスチン誘導体の薬理学的使用
EE9700229A EE03382B1 (et) 1995-03-14 1996-03-12 Tsüstiini mõnede derivaatide farmakoloogiline kasutamine
US08/619,681 US5883126A (en) 1995-03-14 1996-03-12 Pharmacological use of certain cystine derivatives
IL11746596A IL117465A (en) 1995-03-14 1996-03-13 Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
ARP960101738A AR002716A1 (es) 1995-03-14 1996-03-13 Uso farmacologico de ciertos derivados de cistina para la preparacion de un medicamento
NZ303781A NZ303781A (en) 1995-03-14 1996-03-29 Treatment of restenosis using cystine derivatives
PL96322328A PL183234B1 (pl) 1995-03-14 1996-03-29 Farmakologiczne zastosowanie pochodnych cystyny
IS4554A IS4554A (is) 1995-03-14 1997-08-27 Lyfjafræðileg notkun ákveðinna sýstín afleiða
MXPA/A/1997/006825A MXPA97006825A (en) 1995-03-14 1997-09-08 The pharmacological use of certain derivatives of cist
NO974143A NO974143D0 (no) 1995-03-14 1997-09-09 Farmakologisk anvendelse av visse cystinderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives

Publications (1)

Publication Number Publication Date
SE9500897D0 true SE9500897D0 (sv) 1995-03-14

Family

ID=20397536

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500897A SE9500897D0 (sv) 1995-03-14 1995-03-14 The pharmacological use of certain cystine derivatives

Country Status (24)

Country Link
US (1) US5883126A (fr)
EP (1) EP0814798A1 (fr)
JP (1) JPH11501916A (fr)
KR (1) KR19980703055A (fr)
CN (1) CN1183718A (fr)
AR (1) AR002716A1 (fr)
AU (1) AU701287B2 (fr)
BR (1) BR9607225A (fr)
CA (1) CA2214831A1 (fr)
CZ (1) CZ288219B6 (fr)
EE (1) EE03382B1 (fr)
HU (1) HUP9801985A3 (fr)
IL (1) IL117465A (fr)
IS (1) IS4554A (fr)
NO (1) NO974143D0 (fr)
NZ (1) NZ303781A (fr)
PL (1) PL183234B1 (fr)
SE (1) SE9500897D0 (fr)
SK (1) SK282448B6 (fr)
TR (1) TR199700945T1 (fr)
TW (1) TW385249B (fr)
UA (1) UA42830C2 (fr)
WO (1) WO1996028149A1 (fr)
ZA (1) ZA961749B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014306A1 (fr) * 1995-10-17 1997-04-24 Dovetail Technologies, Inc. Stimulants a faible poids moleculaire des cellules de la moelle osseuse et du systeme immunitaire
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
SE9900438D0 (sv) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (fr) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
FR2289179A1 (fr) * 1974-10-28 1976-05-28 Morelle Jean Sels metalliques de lipoaminoacides
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
FR2503151A1 (fr) * 1981-04-02 1982-10-08 Morelle Jean Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
JPS62195356A (ja) * 1986-02-20 1987-08-28 Seiwa Kasei:Kk シスチン誘導体及びその塩
IL98310A (en) * 1990-06-08 1996-08-04 Astra Ab Pharmaceutical compositions comprising cystine derivatives
TW221376B (fr) * 1990-06-28 1994-03-01 Astra Ab
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
EP0746202A4 (fr) * 1992-01-06 1997-06-25 Health Maintenance Programs Composition contenant un anti-oxydant pharmaceutiquement actif et son procede d'utilisation dans la prevention et le traitement d'une restenose apres angioplastie
DE4224670A1 (de) * 1992-07-25 1994-01-27 Boehringer Mannheim Gmbh Verwendung von â,w-Dicarbonsäuren als Fibrinogensenker

Also Published As

Publication number Publication date
EE9700229A (et) 1998-04-15
PL322328A1 (en) 1998-01-19
US5883126A (en) 1999-03-16
IL117465A0 (en) 1996-07-23
SK282448B6 (sk) 2002-02-05
ZA961749B (en) 1996-09-16
AR002716A1 (es) 1998-04-29
NZ303781A (en) 2001-03-30
AU5018596A (en) 1996-10-02
PL183234B1 (pl) 2002-06-28
KR19980703055A (ko) 1998-09-05
CZ280497A3 (cs) 1998-01-14
WO1996028149A1 (fr) 1996-09-19
JPH11501916A (ja) 1999-02-16
IL117465A (en) 2000-07-26
SK120797A3 (en) 1998-02-04
TW385249B (en) 2000-03-21
CZ288219B6 (en) 2001-05-16
NO974143L (no) 1997-09-09
AU701287B2 (en) 1999-01-21
NO974143D0 (no) 1997-09-09
HUP9801985A3 (en) 2000-07-28
MX9706825A (es) 1997-11-29
EE03382B1 (et) 2001-04-16
BR9607225A (pt) 1998-07-07
TR199700945T1 (xx) 1998-02-21
IS4554A (is) 1997-08-27
EP0814798A1 (fr) 1998-01-07
CA2214831A1 (fr) 1996-09-19
CN1183718A (zh) 1998-06-03
UA42830C2 (uk) 2001-11-15
HUP9801985A2 (hu) 1998-12-28

Similar Documents

Publication Publication Date Title
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
BR9508655A (pt) Composição farmacêutica aquosa estéril
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IS4972A (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
DK0706378T3 (da) Ny farmaceutisk formulering.
SE9402453D0 (sv) New pharmaceutical preparation
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
DK0514452T3 (da) Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
PT998287E (pt) Utilizacao de levobupivacaina
NO20004419L (no) Ny anvendelse
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DK0981347T3 (da) Anvendelsen af levobupivacain i ansigtkirurgi
SE9502219D0 (sv) Novel medical use
SE9402880D0 (sv) New peptide derivatives
SE9600120D0 (sv) Novel medical use
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
SE9501881D0 (sv) New pharmacological use of AII-receptor antagonists
DK0787135T3 (da) Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
SE9604752D0 (sv) Formulation and use